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Abstract:
Hyper IgM syndrome is a rare genetically heterogenous
syndrome and is characterized by an elevated or nor-
mal serum IgM and decreased IgG, IgA and IgE, indi-
cating a defect in the class – switch recombination
(CSR) process. Patients are prone to recurrent infec-
tions. X linked variety occurring in males is the most
common form of the disease. Acute Disseminated
Encephalomyelitis (ADEM) in a case of Hyper IgM
syndrome has never been reported. Here we report a
10 years old female with hyper IgM syndrome, possi-
bly autosomal form of the disease, who was admitted
with recurrent vomiting, seizures, encephalopathy, ex-
pressive aphasia and bladder bowel dysfunction and
diagnosed to have ADEM.
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Introduction:
Hyper-IgM syndrome (HIGM) is a rare primary im-
munodeficiency disorder which is characterized by
elevated or normal serum IgM and decreased IgG,
IgA, and IgE due to defective immunoglobulin class
switching. Acute disseminated encephalomyelitis
(ADEM) is traditionally considered a monophasic in-
flammatory demyelinating disorder with pleiotropic
clinical manifestations, which usually includes encepha-
lopathy, but variably includes other focal or multifocal
symptoms suggestive of a central nervous system
(CNS) inflammatory demyelinating disorder.  We re-
port a 10 years female child having Hyper IgM syn-
drome who developed Acute Disseminated Encepha-
lomyelitis.
Case Report:
10 years old female, was admitted with the chief com-
plaint of recurrent fever and vomiting since the last 3
days. She was having recurrent convulsions – gener-
alized tonic clonic in variety (3 episodes) since the
previous evening and had obtunded sensorium. She
had simultaneously developed expressive aphasia
along with loss of control over her bowel and bladder
functions.
She had a past history of recurrent infections since
the age of 3 years resulting in frequent hospital ad-
missions for pneumonia (3 times), empyema, and
chronic suppurative otitis media, generalized lymphad-
enopathy, multiple neck abscesses due to Staphylo-
coccus aureus and Herpetic Whitlow and had been
treated with various antibiotics. Lymph node biopsy
on a previous admission was suggestive of reactive
hyperplasia. Mantoux test was negative.
Her development milestones were appropriate for age.
There was no history of siblings or family members
having a history of recurrent infections. She had re-
ceived all the vaccines as per the National Immuniza-
tion Schedule. There was also no history of receiving
vaccines over the last 1 year.
On clinical examination, she had stable vitals with cer-
vical and inguinal lymphadenopathy. She had no
organomegaly. She had no neck rigidity. Deep ten-
don jerks were diminished on the right side. She also
had extensor planter response on the same side.
Following admission on this occasion, blood count
showed a leukocyte count of 12,300/cumm with 73%
neutrophils and 23% lymphocyte. Hemoglobin was
11.4 gm/dl. Her erythrocyte sedimentation rate, C
reactive protein, electrolytes, blood sugar and other
blood biochemistry were normal. Her plasma ammo-
nia and lactate levels were within normal limit. Lum-
bar puncture had 20 cells/cumm in her cerebrospinal
fluid (CSF) with protein 22.6mg/dl and sugar 65mg/
dl. No organisms were isolated from blood and CSF
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culture. Her immunoglobulin profile was showed IgG
< 30mg/100ml, IgA <20mg/100ml, IgE <0.1 IU/ml
and significantly elevated IgM of 1314/100 ml (nor-
mal 31 - 208 mg/100 ml for age). The levels of CD4
+ T cells were also demised.
Magnetic Resonance Imaging Scan of brain showed
features suggestive of multiple hyper intensities in the
cortical and subcortical region (bilateral fronto pari-
etal lobes, left cerebellar hemisphere) and
periventricular white matter due to Acute Dissemi-
nated Encephalomyelitis (Fig. 1).
toms subsided. She was discharged after 14 days with
oral steroids and is presently receiving monthly infu-
sion of Immunoglobulin and is in regular follow up.
She is also on prophylaxis with cotrimoxazole.
Discussion:
Hyper-IgM syndromes are a group of primary
immunodeficiency’s whose molecular basis is still un-
known. The most common variant is the X-linked form
of disease (XHIGM), due to mutations in the CD40
ligand–encoding gene (CD40LG). Mutations
in CD40, activation-induced cytidine deaminase
(AICDA), and uracil glycosylase (UNG) are respon-
sible for autosomal recessive forms of HIGM  [1, 2].
Our patient being a female child is unlikely to be the
X linked recessive form of the disorder and is more
likely to be autosomal recessive.
There is normal B cell count, but abnormal interac-
tions between B and T cells leading to impaired class
switching mechanism. The immune defect extends
beyond the CSR defect and also involves maturation
of dendritic cells and T cell priming. Recurrent infec-
tions in the respiratory tract and gastrointestinal prob-
lems are the most common clinical manifestation. They
also have a high risk of opportunistic infections with
Cryptosporidiosis, Pneumocystic jiroveci, Cytome-
galovirus and Mycobacterium. Our index case had
been admitted several times with pneumonia. She also
had Staphylococcus aureus isolated from abscesses
in the neck. There was also a history of herpetic whit-
low. Some patients are also prone to autoimmune dis-
orders like anemia, thrombocytopenia, hepatitis etc.
Immunoglobulin replacement is the mainstay of treat-
ment of all forms of HIGM, and may improve clinical
outcome [1, 2]. In spite of this treatment, prognosis
remains poor. About half the patients will die by the
third decade of life, and many others develop chronic
morbidities during childhood.
Acute disseminated encephalomyelitis (ADEM) is an
autoimmune demyelinating disease of the central ner-
vous system that typically follows a febrile infection
Fig. 1: Multiple hyper intensities in the cortical
and subcortical region (bilateral fronto parietal
lobes, left cerebellar hemisphere) and
periventricular white matter due to ADEM.
On being diagnosed with Hyper IgM syndrome, she
was given 500mg/kg of intra venous Immunoglobulin
(Immunoglobulin replacement therapy). Thereafter she
was also treated with IV methylprednisolone at 30mg/
kg/day for 5 days for ADEM. This was followed with
oral prednisolone at 2mg/kg/day. Inj Phenytoin was
given for controlling her seizures. Gradually over the
next 72 hours her sensorium improved and her symp-     Journal of Krishna Institute of Medical Sciences University
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or a vaccination. Children are predominantly affected
[3]. A plethora of viral and bacterial pathogens and a
number of vaccinations have been associated with
ADEM [4, 5].
There are reports of association of ADEM in patients
with common variable immunodeficiency [6]. There
is also a report of ADEM being the first manifestation
in a patient with CVID (7).
However, to our knowledge there is no reported case
of patients with Hyper IgM syndrome developing
acute disseminated encephalomyelitis though the ten-
dency to develop autoimmune disease is common in
them.
Based on the presumed autoimmune etiology of
ADEM, the common treatment approach consists of
intravenous methylprednisolone at a dosage of 20 to
30 mg/kg per day (maximum 1 g/day) for 3 to 5 days,
followed by an oral corticosteroid taper of 4 to
6 weeks [8]. We applied a similar treatment protocol
for treating our patient, to which she has responded.
In case of insufficient response or contraindications
to corticosteroids, intravenous immunoglobulin G
(IVIg) at a dosage of 2 g/kg divided over 2 to 5 days
is a therapeutic option [8].
 Immunoglobulin replacement therapy also reduces the
incidence of infections in patients with Hyper IgM
syndrome [1]. It also reduces the likelihood of lym-
phoid hypertrophy. Our patient is presently being given
immunoglobulin every month.
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